For children aged 9 to 14 years with suspected opioid overdose, what is the Naloxone dose?

Prepare for the ICEMA Medication Standing Orders Test. Hone your knowledge with questions and detailed explanations on various medications and protocols. Excel on your exam!

Multiple Choice

For children aged 9 to 14 years with suspected opioid overdose, what is the Naloxone dose?

Explanation:
Naloxone is given to rapidly reverse opioid-induced respiratory depression by displacing opioids from mu receptors. For children in the 9–14 year age range, the starting dose in this setting is a moderate fixed amount of 0.5 mg, given by IM, IN, IV, or IO routes. This dose is chosen because it provides prompt reversal in most children of this size while remaining easy to administer quickly in the field; it also allows safe titration—if there isn’t adequate improvement, you can repeat and adjust the dose every couple of minutes. Intranasal administration is especially convenient in pediatric patients due to its noninvasive nature, but any of the approved routes can be used depending on what’s available and the patient’s condition. Remember that naloxone acts quickly but is shorter-acting than some opioids, so ongoing monitoring and potential repeat dosing may be necessary if a longer-acting opioid is involved.

Naloxone is given to rapidly reverse opioid-induced respiratory depression by displacing opioids from mu receptors. For children in the 9–14 year age range, the starting dose in this setting is a moderate fixed amount of 0.5 mg, given by IM, IN, IV, or IO routes. This dose is chosen because it provides prompt reversal in most children of this size while remaining easy to administer quickly in the field; it also allows safe titration—if there isn’t adequate improvement, you can repeat and adjust the dose every couple of minutes. Intranasal administration is especially convenient in pediatric patients due to its noninvasive nature, but any of the approved routes can be used depending on what’s available and the patient’s condition. Remember that naloxone acts quickly but is shorter-acting than some opioids, so ongoing monitoring and potential repeat dosing may be necessary if a longer-acting opioid is involved.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy